Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Notes Payables (2023)

Adagio Medical Holdings (ADGM) has disclosed Notes Payables for 1 consecutive years, with $36.4 million as the latest value for Q4 2023.

  • Quarterly Notes Payables changed N/A to $36.4 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $36.4 million through Dec 2023, changed N/A year-over-year, with the annual reading at $36.4 million for FY2023, N/A changed from the prior year.
  • Notes Payables for Q4 2023 was $36.4 million at Adagio Medical Holdings.
  • The five-year high for Notes Payables was $36.4 million in Q4 2023, with the low at $36.4 million in Q4 2023.